LMNOOP Psoriasis Treatment Cream

Manufacturer
Shenzhen Ishan Technology Co., Ltd
Effective date
2023-10-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:22:39

Label at a glance#

ProductLMNOOP Psoriasis Treatment Cream
Active ingredientSALICYLIC ACID
Label structure11 sections

Indications and uses

Anti-bacterial, reduces itchy and painful skin conditions due to eczema, athletes foot, psoriasis, jock itch, rash, skin yeast infection and more.

Dosage and administration

Wash and dry affected area, apply a thin layer of LMNOOP over affected area, gently massage until fully absorbed, repeat 2-3 times daily.

Storage and handling

Store at room temperature.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Colloidal Oatmeal--1%--Skin protectant.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Purify water, dictamnus dasycarpus root, stellera chamaejasme whole, sophora flavescens root, cnidium monnieri fruit, phellodendron chinense whole, bassia scoparia fruit, Menthol.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

if swallowed, call poison control or seek medical help.

Ask a doctor

OTC - ASK DOCTOR/PHARMACIST SECTION

before using on children under 2 years of age.

Stop use

OTC - STOP USE SECTION

if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days, or there is no improvement of athlete's foot or psoriasis within 4 weeks or jock itch with 2 weeks.

Uses

OTC - PURPOSE SECTION

Anti-bacterial, reduces itchy and painful skin conditions due to eczema, athletes foot, psoriasis, jock itch, rash, skin yeast infection and more.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature.

Directions

INDICATIONS & USAGE SECTION

Wash and dry affected area, apply a thin layer of LMNOOP over affected area, gently massage until fully absorbed, repeat 2-3 times daily.

When using this product

USER SAFETY WARNINGS SECTION

o not get into eyes. do not apply to wounds or damaged skin.

Warnings

WARNINGS SECTION

For external only

Lable

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73076-112-012025-01-30C16284748780-12cef2736-a011-d83d-e063-dadaa90ab31fe88db9ec-3a41-cc1e-e053-2995a90af475
73076-112-022025-01-30C16284748780-12cef2736-a011-d83d-e063-dadaa90ab31fe88db9ec-3a41-cc1e-e053-2995a90af475

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73076-112-01LMNOOP Psoriasis Treatment Cream50 g in 1 PACKAGECREAM502
73076-112-02LMNOOP Psoriasis Treatment Cream100 g in 1 BOTTLECREAM1002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73076-112LMNOOP PSORIASIS TREATMENT CREAM (PSORIASIS TREATMENT CREAM) CREAM [SHENZHEN ISHAN TECHNOLOGY CO., LTD]2Legacy NDC, 2 package rows20231018_e88db9ec-3a41-cc1e-e053-2995a90af475.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73076-11273076-112-01, 73076-112-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
07e6f0d8-216d-15ef-e063-6294a90ade1ee88db9ec-3a41-cc1e-e053-2995a90af4752023-10-17WarningsExact identifier
spl id: 07e6f0d8-216d-15ef-e063-6294a90ade1e
spl set id: e88db9ec-3a41-cc1e-e053-2995a90af475

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.